Modelling the enhancement of fractionated radiotherapy by gene transfer to sensitize tumour cells to radiation

Radiotherapy and Oncology

Volumn 48, Issue 1, 1998, Pages 5-13

  Wheldon, Thomas E ^a   Mairs, Robert J ^a   Rampling, Roy P ^a,b   Barrett, Ann ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

Author keywords

Fractionated radiotherapy; Gene therapy; Radiosensitizers

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER RADIOTHERAPY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MODEL; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION;

GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MODELS, THEORETICAL; NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; TRANSFECTION;

EID: 0031821737     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00022-X     Document Type: Article

References (37)

1. Alexander, I.E., Russell, D.W., Spence, A.M. and Miller, A.D. Effects of gamma irradiation on the transduction of dividing and non-dividing cells in brain and muscle of rats by adeno-associated virus vector. Hum. Gene Ther. 7: 841-850, 1996.
2. Bleehan, N.M., Stenning, S.P. and MRC Brain Tumour Working Party. A Medical Research Council Trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br. J. Cancer 64: 769-774, 1991.
3. Brem, H., Piantadosi, S., Burger, P.C., et al. Placebo controlled trial of safety and efficacy of intraoperative controlled delivery by biopolymers of chemotherapy for recurrent gliomas. Lancet 345: 1008-1012, 1995.
4. Buchsbaum, D.J., Raben, D., Stackhouse, M.A., et al. Approaches to enhance cancer radiotherapy employing gene transfer methods. Gene Ther. 3: 1042-1068, 1996.
5. Chambers, R., Gillespie, G.Y., Soroceanu, S., et al. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumours in a scid mouse model of human malignant glioma. Proc. Natl. Acad. Sci. USA 92: 1411-1415, 1995.
6. Chen, S.H., Shine, H.D., Goodman, J.C., Grossman, R.G. and Woo, S.L.C. Gene therapy for brain tumor: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91: 3054-3057, 1994.
7. Cunliffe, P.N., Mann, J.R., Cameron, A.H., Roberts, K.D. and Ward, H.W.C. Radiosensitivity in ataxia telangiectasia. Br. J. Radiol. 48: 374-376, 1975.
8. Cusack, J.C., Spitz, F.R., Nguyen, D., Zhang, W.-W., Cristiano, R.J. and Roth, J.A. High levels of gene transduction in human lung tumours following intralesional injection of recombinant adenovirus. Cancer Gene Ther. 3: 245-249, 1996.
9. Dahlberg, W.K. and Little, J.B. Response of dermal fibroblast cultures from patients with unusually severe responses to radiotherapy and from ataxia telangiectasia heterozygotes to fractionated radiation. Clin. Cancer Res. 1: 785-790, 1995.
10. Deschavanne, P.J. and Fertil, B. A review of human cell radiosensitivity in vitro. Int. J. Radiat. Oncol. Biol. Phys. 34: 251-261, 1996.
11. Gallardo, D., Drazan, K.E. and McBride, W.H. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumour radiosensitivity. Cancer Res. 56: 4891-4893, 1996.
12. Goodhead, D.T. Initial events in the cellular effects of ionising radiation: clustered damage in DNA. Int. J. Radiat. Biol. 65: 7-17, 1994.
13. Kesari, S., Randazzo, R.B., Valyi-Nagi, T., et al. Therapy of experimental human brain tumours using a neuroattenuated herpes simplex virus mutant. Lab. Invest. 73: 636-648, 1995.
14. Kim, J.H., Kim, S.H., Kolosvary, A., Brown, S.L., Kim, O.B. and Freytag, S.O. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo. Int. J. Radiat. Oncol. Biol. Phys. 33: 861-868, 1995.
15. McBride, W.H. and Dougherty, G.J. Radiotherapy for genes that cause cancer. Nat. Med. 1: 1215-1217, 1995.
16. McKie, E.A., MacLean, A.R., Lewis, A.D., et al. Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours - evaluation of a potentially effective clinical therapy. Br. J. Cancer 74: 745-752, 1996.
17. MacLean, A.R., Fareed, M.U., Robertson, L., Harland, J. and Brown, S.M. Herpes simplex virus type 1 variants 1714 and 1716 pinpoint neovirulence related sequences in Glasgow strain 17 + between early gene 1 and the 'a' sequence. J. Genet. Virol. 72: 631-639, 1991.
18. McMillan, T.J. Gene manipulation in radiotherapy. Lancet 347: 632, 1996.
19. Mineta, T., Rabkin, S., Yakazi, T., Hunter, W. and Martuza, R. Attenuated multi mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat. Med. 1: 938-943, 1995.
20. Nguyen, D.M., Wiehle, S.A., Roth, J.A. and Cristiano, R.J. Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex. Cancer Gene Ther. 4: 183-190, 1997.
21. Nowak, R. Discovery of AT gene brings biomedical research bonanza. Science 268: 1700-1701, 1995.
22. Oldfield, E.H., Ram, Z., Culver, K.W., Blaese, R.M., Devroom, H.L. and Anderson, W.F. (1993) Gene therapy for the treatment of brain tumours using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther. 4: 36-69, 1993.
23. Randazzo, R.B., Kesari, S., Gesser, D., et al. Treatment of experimental murine intracranial murine melanoma with neuroattenuated herpes simplex virus type 1 mutant. Virology 211: 94-101, 1995.
24. Ross, G.M., Eady, J.J., Mithal, N.P., et al. DNA strand break rejoining defect in xrs-6 is complemented by transfection with the human Ku80 gene. Cancer Res. 55: 1235-1238, 1995.
25. Russ, A.P., Friedel, C., Grez, M. and Von Melchner, H. Self-deleting retrovirus vectors for gene-therapy. J. Virol. 70: 4927-4932, 1996.
26. Savitsky, K., Bar-Shira, A., Gilad, S., et al. A single ataxia telangiectasia gene with a product similar to P1-3 kinase. Science 268: 1749-1753, 1995.
27. Suresh, A., Tung, F., Moreb, J. and Zucali, J.R. Role of manganese superoxide dismutase in radioprotection using gene transfer studies. Cancer Gene Ther. 1: 85-90, 1994.
28. Taha, M.Y., Clements, G.B. and Brown, S.M. The herpes simplex virus type 2 1488bp deletion which eliminates neurovirulence in mice. J. Genet. Virol. 70: 3073-3078, 1989.
29. Taha, M.Y., Brown, S M., Clements, J.B. and Graham, D.I. The JH 2604 deletion variant of herpes simplex virus type 2 fails to produce necrotising encephalitis following intracranial inoculation of mice. J. Genet. Virol. 71: 1597-1601, 1990.
30. Tambini, C.E., George, A.M., Rommens, J.M, Tsui, L.C., Scherer, S.W. and Thacker, J. The XRCC2 repair gene: identification of a positional candidate. Genomics 41: 84-92, 1997.
31. Tripathy, S.K., Black, H.B., Goldwasser, E. and Leiden, J.M. Immune responses to transgene-encoded proteins limit the stability of gene expression after the injection of replication-defective adenovirus vectors. Nature Med. 2: 545-550, 1996.
32. Vile, R.G. and Hart, I.R. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res, 53: 962-967, 1993.
33. Vile, R.G. Tumour specific gene expression. Semin. Cancer Biol. 5: 437-443, 1994.
34. Walker, M.D., Alexander, E., Hunt, W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg. 49: 333-343, 1978.
35. Weichselbaum, R.R., Hallahan, D.E., Becket, M.A., et al. Gene therapy targeted by radiation preferentially radiosensitises tumor cells. Cancer Res. 54: 4266-4269, 1994.
36. Weichselbaum, R.R. and Kufe, D. Gene therapy of cancer. Lancet Suppl II: S10-S12, 1997.
37. Zeng, M., Cerniglia, G.J., Eck, S.L. and Stephens, C.W. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionising radiation. Human Gene Therapy 8: 1025-1032, 1997.